Methylphenidate Transdermal System, CII

DAYTRANA® (methylphenidate transdermal system), CII is no longer being marketed. An FDA-approved authorized generic version is available.

The authorized generic methylphenidate transdermal system is made in the same manufacturing plant, under the same conditions, processes, chemical ingredients and formulation as the Daytrana branded product. This includes original Daytrana logo backing.

For more information, please contact Padagis at (800) 775-2054 or info@padagis.com.

You should not make any changes to any treatment plan without consulting your healthcare provider.

DAYTRANA® (methylphenidate transdermal system), CII is no longer being marketed. An FDA-approved authorized generic version is available.